Glatiramer Acetate Injection, Solution
Product Images NDC 11797-765

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glatiramer Acetate (NDC 11797-765). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Italfarmaco Spa, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

20 mg Container Label (Glatiramer 01)

This text is about Glatiramer Acetate injection for subcutaneous use. It mentions single-dose pre-filled syringes and provides information such as manufacturer details and usage instructions. The product seems to be available in doses of 20mg.*

FDA Label Image

20 mg Container Label (Glatiramer 02)

This description discusses Glatiramer Acetate Injection, which is intended for subcutaneous administration. The medication is stored in refrigerated conditions between 2°C to 8°C. Each prefilled syringe contains a specific dosage of the Glatiramer Acetate solution. It is recommended to consult the enclosed Medication Guide for each patient. The medication is available by prescription only and should be administered as directed, typically three times a week.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.